The antibiotic aklavin was isolated in 1956 from culture liquids of an unknown streptomycete obtained from soil samples originating in Aklavik, Canada1). It showed activity against various bacteriophages, gram-positive bacteria, and some fungi and viruses. Following preliminary characterization, it was subjected to acid hydrolysis, which cleaved it into an aglycone and a basic sugar or sugars. The structure of this aglycone, aklavinone, was shown to be 1-deoxy-I-pyrromycinone2'. However, the sugar moiety never was identified.
More recently the discovery and structure elucidation of the antibiotic aclacinomycin (II) was reported3). Although this antibiotic contains the same aglycone as aklavin, it has much superior antibacterial and antitumor activity. Since this difference in biological activity obviously resides in the sugar portion of the two molecules, it seemed worthwhile to elucidate the sugar or sugars present in aklavin for the purpose of defining structure-activity relationships. CDCl3 was used as the solvent and as the deuterium signal for the fieldfrequency lock channel. Chemical shifts were measured against internal TMS. Thus it appeared that aklavin was identical with 1-deoxypyrromycin (I), which already had been reported as a product of the partial hydrolysis of aclacinomycin3). We repeated this partial hydrolysis under the specified conditions, but found them too vigorous. Better yields of 1-deoxypyrromycin were obtained by treating a methylene chloride solution of aclacinomycin (6 mg in 4 ml) with 2-3 drops of 1 % methanolic hydrogen chloride. The reaction was complete at 25°C in 10 minutes. The sample prepared in this manner had Rf values identical with those of aklavin in two different solvent systems: chloroform -methanol (4: 1) and ethyl acetate -methanol (3: 7) on silica gel plates. A hydrolysis sample purified by chromatography in the former system had an infrared absorption spectrum superimposable with that of aklavin hydrochloride. 
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